[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States RNA Interference (RNAi) Drug Delivery Market Report 2017

July 2017 | 111 pages | ID: U01696D7E2CEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States RNA Interference (RNAi) Drug Delivery market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of RNA Interference (RNAi) Drug Delivery in these regions, from 2012 to 2022 (forecast).
United States RNA Interference (RNAi) Drug Delivery market competition by top manufacturers/players, with RNA Interference (RNAi) Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Metabolic disorders
  • Alnylam Pharmaceuticals Inc
  • Merck & Co. Inc
  • Access Pharmaceuticals Inc
  • Dicerna Pharmaceuticals Inc
  • Calondo Pharmaceuticals Inc
  • Marina Biotech Inc
  • RXi Pharmaceuticals Corp
  • Quark Pharmaceuticals Inc
  • Silence Therapeutics plc
  • Tacere Therapeutics Inc
  • PhaseRx Inc
  • Sirnaomics Inc
  • Traversa Therapeutics Inc
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Nanoparticle Drug Delivery Technology
  • Pulmonary Drug Delivery Technology
  • Nucleic Acid Drug Delivery Technology
  • Aptamer Drug Delivery Technology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of RNA Interference (RNAi) Drug Delivery for each application, including
  • Infectious Diseases
  • Cardiology
  • Oncology
  • Neurology
  • Ophthalmology
  • Metabolic Disorders
If you have any special requirements, please let us know and we will offer you the report as you want.
United States RNA Interference (RNAi) Drug Delivery Market Report 2017

1 RNA INTERFERENCE (RNAI) DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of RNA Interference (RNAi) Drug Delivery
1.2 Classification of RNA Interference (RNAi) Drug Delivery by Product Category
  1.2.1 United States RNA Interference (RNAi) Drug Delivery Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States RNA Interference (RNAi) Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Nanoparticle Drug Delivery Technology
  1.2.4 Pulmonary Drug Delivery Technology
  1.2.5 Nucleic Acid Drug Delivery Technology
  1.2.6 Aptamer Drug Delivery Technology
1.3 United States RNA Interference (RNAi) Drug Delivery Market by Application/End Users
  1.3.1 United States RNA Interference (RNAi) Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Infectious Diseases
  1.3.3 Cardiology
  1.3.4 Oncology
  1.3.5 Neurology
  1.3.6 Ophthalmology
  1.3.7 Metabolic Disorders
1.4 United States RNA Interference (RNAi) Drug Delivery Market by Region
  1.4.1 United States RNA Interference (RNAi) Drug Delivery Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West RNA Interference (RNAi) Drug Delivery Status and Prospect (2012-2022)
  1.4.3 Southwest RNA Interference (RNAi) Drug Delivery Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic RNA Interference (RNAi) Drug Delivery Status and Prospect (2012-2022)
  1.4.5 New England RNA Interference (RNAi) Drug Delivery Status and Prospect (2012-2022)
  1.4.6 The South RNA Interference (RNAi) Drug Delivery Status and Prospect (2012-2022)
  1.4.7 The Midwest RNA Interference (RNAi) Drug Delivery Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of RNA Interference (RNAi) Drug Delivery (2012-2022)
  1.5.1 United States RNA Interference (RNAi) Drug Delivery Sales and Growth Rate (2012-2022)
  1.5.2 United States RNA Interference (RNAi) Drug Delivery Revenue and Growth Rate (2012-2022)

2 UNITED STATES RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States RNA Interference (RNAi) Drug Delivery Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States RNA Interference (RNAi) Drug Delivery Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States RNA Interference (RNAi) Drug Delivery Average Price by Players/Suppliers (2012-2017)
2.4 United States RNA Interference (RNAi) Drug Delivery Market Competitive Situation and Trends
  2.4.1 United States RNA Interference (RNAi) Drug Delivery Market Concentration Rate
  2.4.2 United States RNA Interference (RNAi) Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers RNA Interference (RNAi) Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RNA INTERFERENCE (RNAI) DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States RNA Interference (RNAi) Drug Delivery Sales and Market Share by Region (2012-2017)
3.2 United States RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Region (2012-2017)
3.3 United States RNA Interference (RNAi) Drug Delivery Price by Region (2012-2017)

4 UNITED STATES RNA INTERFERENCE (RNAI) DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States RNA Interference (RNAi) Drug Delivery Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States RNA Interference (RNAi) Drug Delivery Revenue and Market Share by Type (2012-2017)
4.3 United States RNA Interference (RNAi) Drug Delivery Price by Type (2012-2017)
4.4 United States RNA Interference (RNAi) Drug Delivery Sales Growth Rate by Type (2012-2017)

5 UNITED STATES RNA INTERFERENCE (RNAI) DRUG DELIVERY SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States RNA Interference (RNAi) Drug Delivery Sales and Market Share by Application (2012-2017)
5.2 United States RNA Interference (RNAi) Drug Delivery Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES RNA INTERFERENCE (RNAI) DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Metabolic disorders
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Alnylam Pharmaceuticals Inc
  6.2.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck & Co. Inc
  6.3.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Access Pharmaceuticals Inc
  6.4.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Dicerna Pharmaceuticals Inc
  6.5.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Calondo Pharmaceuticals Inc
  6.6.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Marina Biotech Inc
  6.7.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 RXi Pharmaceuticals Corp
  6.8.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Quark Pharmaceuticals Inc
  6.9.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Silence Therapeutics plc
  6.10.2 RNA Interference (RNAi) Drug Delivery Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Tacere Therapeutics Inc
6.12 PhaseRx Inc
6.13 Sirnaomics Inc
6.14 Traversa Therapeutics Inc

7 RNA INTERFERENCE (RNAI) DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 RNA Interference (RNAi) Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 RNA Interference (RNAi) Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of RNA Interference (RNAi) Drug Delivery Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RNA INTERFERENCE (RNAI) DRUG DELIVERY MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States RNA Interference (RNAi) Drug Delivery Sales Volume, Revenue Forecast (2017-2022)
11.2 United States RNA Interference (RNAi) Drug Delivery Sales Volume Forecast by Type (2017-2022)
11.3 United States RNA Interference (RNAi) Drug Delivery Sales Volume Forecast by Application (2017-2022)
11.4 United States RNA Interference (RNAi) Drug Delivery Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of RNA Interference (RNAi) Drug Delivery
Figure United States RNA Interference (RNAi) Drug Delivery Market Size (K Units) by Type (2012-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume Market Share by Type (Product Category) in 2016
Figure Nanoparticle Drug Delivery Technology Product Picture
Figure Pulmonary Drug Delivery Technology Product Picture
Figure Nucleic Acid Drug Delivery Technology Product Picture
Figure Aptamer Drug Delivery Technology Product Picture
Figure United States RNA Interference (RNAi) Drug Delivery Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of RNA Interference (RNAi) Drug Delivery by Application in 2016
Figure Infectious Diseases Examples
Table Key Downstream Customer in Infectious Diseases
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Neurology Examples
Table Key Downstream Customer in Neurology
Figure Ophthalmology Examples
Table Key Downstream Customer in Ophthalmology
Figure Metabolic Disorders Examples
Table Key Downstream Customer in Metabolic Disorders
Figure United States RNA Interference (RNAi) Drug Delivery Market Size (Million USD) by Region (2012-2022)
Figure The West RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales (K Units) and Growth Rate (2012-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States RNA Interference (RNAi) Drug Delivery Sales Share by Players/Suppliers
Figure 2017 United States RNA Interference (RNAi) Drug Delivery Sales Share by Players/Suppliers
Figure United States RNA Interference (RNAi) Drug Delivery Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States RNA Interference (RNAi) Drug Delivery Revenue Share by Players/Suppliers
Figure 2017 United States RNA Interference (RNAi) Drug Delivery Revenue Share by Players/Suppliers
Table United States Market RNA Interference (RNAi) Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market RNA Interference (RNAi) Drug Delivery Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States RNA Interference (RNAi) Drug Delivery Market Share of Top 3 Players/Suppliers
Figure United States RNA Interference (RNAi) Drug Delivery Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers RNA Interference (RNAi) Drug Delivery Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers RNA Interference (RNAi) Drug Delivery Product Category
Table United States RNA Interference (RNAi) Drug Delivery Sales (K Units) by Region (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Sales Share by Region (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Share by Region (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Region in 2016
Table United States RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Revenue Share by Region (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Revenue Market Share by Region in 2016
Table United States RNA Interference (RNAi) Drug Delivery Price (USD/Unit) by Region (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Sales (K Units) by Type (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Sales Share by Type (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Share by Type (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Type in 2016
Table United States RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Revenue Share by Type (2012-2017)
Figure Revenue Market Share of RNA Interference (RNAi) Drug Delivery by Type (2012-2017)
Figure Revenue Market Share of RNA Interference (RNAi) Drug Delivery by Type in 2016
Table United States RNA Interference (RNAi) Drug Delivery Price (USD/Unit) by Types (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Growth Rate by Type (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Sales (K Units) by Application (2012-2017)
Table United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Application (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Market Share by Application in 2016
Table United States RNA Interference (RNAi) Drug Delivery Sales Growth Rate by Application (2012-2017)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Growth Rate by Application (2012-2017)
Table Metabolic disorders Basic Information List
Table Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Metabolic disorders RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Metabolic disorders RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Alnylam Pharmaceuticals Inc Basic Information List
Table Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Alnylam Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Merck & Co. Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Access Pharmaceuticals Inc Basic Information List
Table Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Access Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Dicerna Pharmaceuticals Inc Basic Information List
Table Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Dicerna Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Calondo Pharmaceuticals Inc Basic Information List
Table Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Calondo Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Marina Biotech Inc Basic Information List
Table Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Marina Biotech Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table RXi Pharmaceuticals Corp Basic Information List
Table RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure RXi Pharmaceuticals Corp RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Quark Pharmaceuticals Inc Basic Information List
Table Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Quark Pharmaceuticals Inc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Silence Therapeutics plc Basic Information List
Table Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales Growth Rate (2012-2017)
Figure Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Sales Market Share in United States (2012-2017)
Figure Silence Therapeutics plc RNA Interference (RNAi) Drug Delivery Revenue Market Share in United States (2012-2017)
Table Tacere Therapeutics Inc Basic Information List
Table PhaseRx Inc Basic Information List
Table Sirnaomics Inc Basic Information List
Table Traversa Therapeutics Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of RNA Interference (RNAi) Drug Delivery
Figure Manufacturing Process Analysis of RNA Interference (RNAi) Drug Delivery
Figure RNA Interference (RNAi) Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of RNA Interference (RNAi) Drug Delivery Major Players/Suppliers in 2016
Table Major Buyers of RNA Interference (RNAi) Drug Delivery
Table Distributors/Traders List
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Price (USD/Unit) Trend Forecast (2017-2022)
Table United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Type in 2022
Table United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Application in 2022
Table United States RNA Interference (RNAi) Drug Delivery Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States RNA Interference (RNAi) Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume Share Forecast by Region (2017-2022)
Figure United States RNA Interference (RNAi) Drug Delivery Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories